SouthState’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$24.6K Buy
47
+2
+4% +$1.02K ﹤0.01% 590
2026
Q2
$22.4K Sell
45
-2
-4% -$886 ﹤0.01% 600
2026
Q1
$21K Sell
47
-15
-24% -$6.99K ﹤0.01% 560
2025
Q4
$28.1K Buy
62
+15
+32% +$6.46K ﹤0.01% 531
2025
Q3
$18.4K Sell
47
-31
-40% -$13K ﹤0.01% 582
2025
Q2
$34.7K Sell
78
-50
-39% -$23K ﹤0.01% 553
2025
Q1
$62.1K Buy
128
+111
+653% +$51.7K ﹤0.01% 493
2024
Q4
$6.85K Buy
17
+8
+89% +$3.71K ﹤0.01% 531
2024
Q3
$4.19K Hold
9
– – ﹤0.01% 537
2024
Q2
$4.22K Buy
9
+7
+350% +$3.04K ﹤0.01% 546
2024
Q1
$836 Buy
+2
New +$845 ﹤0.01% 655

Other funds holding VRTX

SouthState's VRTX Position: Q3 2026 in Review

SouthState increased its Vertex Pharmaceuticals (VRTX) stake by 4.4% in Q3 2026, buying an estimated $1.02K and bringing the position to 47 shares worth $24.6K. The position accounts for ﹤0.01% of the portfolio, ranked #590.

SouthState first reported a position in VRTX in Q1 2024 and has held it in 11 quarters since. The position peaked at $62.1K in Q1 2025. 1,564 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • SouthState held 47 shares of Vertex Pharmaceuticals worth $24.6K as of Q3 2026.
  • SouthState bought 2 Vertex Pharmaceuticals shares in Q3 2026, an estimated $1.02K.
  • Vertex Pharmaceuticals made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #590 holding.
  • SouthState first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 11 quarters since.
  • SouthState's Vertex Pharmaceuticals position peaked at $62.1K in Q1 2025.
  • 1,564 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.